Navigation Links
Skin Pain, Sensitivity Rises With Migraine
Date:4/23/2008

Almost two-thirds of people with these headaches suffer from skin discomfort, study finds,,,,

WEDNESDAY, April 23 (HealthDay News) -- People who have migraines -- either chronic or episodic -- are more likely to suffer from serious skin pain and sensitivity, new research shows.

As many as two-thirds of those affected by migraines may also experience a condition called cutaneous allodynia. Cutaneous allodynia is skin sensitivity and pain so severe that everyday activities like brushing your hair or wearing jewelry can cause pain.

"The phenomenon of cutaneous allodynia seems to be correlated to true migraine," said headache expert Dr. Bruce Silverman, a neurologist at Providence Hospital and Medical Centers in Southfield, Mich. "For those with migraine and cutaneous allodynia, the idea of treating prior to the onset of symptoms may offer a greater response."

To assess the prevalence of cutaneous allodynia, researchers led by Dr. Marcelo Bigal, of Albert Einstein College of Medicine, New York City, surveyed almost 17,000 people who experienced headaches. Their questionnaires asked about the type of headaches suffered, how often, whether or not their quality of life was affected, whether or not they suffered from depression, or if they had any other illnesses that might cause pain. Survey participants were also asked to complete the allodynia symptom checklist (ASC), an assessment tool previously designed by the study's authors.

The study, which is in the April 22 issue of the journal Neurology, found that almost 12,000 people reported suffering from migraines. Another 1,491 had headaches that were probably migraines, and 3,345 experienced other types of headaches, such as tension headaches.

Of those who reported having chronic migraines -- daily headaches -- 68 percent also experienced cutaneous allodynia. In those with episodic migraines, 63 percent also experienced the condition. Just 42 percent of those with suspected migraine reported cutaneous allodynia, and about 37 percent of those with other types of headaches reported allodynia, as well.

In people with migraine, cutaneous allodynia was more common in women, in those who had headaches more often, in people with a higher body mass index, and in those disabled or depressed.

The study was sponsored by the National Headache Foundation through a grant from Ortho-McNeil Neurologics Inc., a pharmaceutical company that makes Axert, a drug that's part of a class of medications known as triptans that are used to treat migraine in its acute stages, and Topamax, a preventive migraine medication. Bigal is currently an employee of Merck & Co., the maker of Maxalt, another triptan medication.

"This study highlights the importance of early treatment in migraine," according to Silverman, who was not involved in the research. He explained that by the time someone is experiencing cutaneous allodynia, triptan medications tend not to be as effective as when they're taken early on in a migraine.

"When you delay treating and don't take a triptan right away, it doesn't work as well. It gets harder and harder to get rid of," agreed Dr. Keith Siller, an assistant professor of neurology at New York University Medical Center in New York City.

He said this study's findings might help differentiate true migraines from other types of headaches, such as tension headaches, but that he wasn't familiar with the allodynia symptom checklist used in this study.

If you've been diagnosed with migraine and haven't found relief, Siller suggested seeing a neurologist, because there are preventive medications available.

More information

To learn more about migraine, visit the American Academy of Family Physicians.



SOURCES: Keith Siller, M.D., assistant professor, neurology, New York University Medical Center, New York City; Bruce Silverman, D.O., neurologist, Providence Hospital and Medical Center, Southfield, Mich.; April 22, 2008, Neurology


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
2. Massage Eases Pain, Anxiety After Surgery
3. MRE could provide a definitive diagnosis for people with muscle pain, Mayo Clinic study shows
4. Reflux Can Precipitate Chest Pain, Cough
5. Proper Mattress Can Improve Sleep Comfort, Reduce Pain, Says American Chiropractic Association
6. Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
9. Routinely used diagnostic approaches: only limited diagnostic sensitivity for bile duct cancer?
10. Test Detects Sensitivity to HIV Drug
11. Cocaine Use Dulls Brains Sensitivity to Rewards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Skin Pain, Sensitivity Rises With Migraine
(Date:2/26/2017)... VA (PRWEB) , ... February 26, 2017 , ... ODH, ... Managed Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ... with PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ...
(Date:2/25/2017)... ... , ... FCPX users now have the ability to sharpen a desired color ... users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, ... users can visually see the color range effected with ease all within Final ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after ... Travel Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run ... 420-page book measures almost a metre across when open, weighs in at more than ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. ... announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as ... beginning April 10. Dr. Bell comes to Liberty from the Ohio University Heritage ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... and hearing disabilities, it is so critically important that we all are aware ... That is why Mediaplanet is proud to announce the launch of its newest ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Laboratories, Inc. (NASDAQ: IPXL ) today announced that it plans ... Raymond James and Associates, 38 th Annual Institutional Investors ... Orlando, FL. Cowen and Company 37 th ... 2017 in Boston, MA. Barclays ... Miami, FL. Individuals may listen ...
(Date:2/27/2017)... PETACH TIKVAH, Israel , Feb. 27, ... a leading developer of adult stem cell technologies for ... S. Almenoff , M.D., Ph.D., FACP, and Arturo ... Directors.  "Dr. Almenoff and Mr. Araya ... at an exciting time for our company," said ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Wireless Health Market is ... next decade to reach approximately $330.5 billion by 2025. ... the given segments on global as well as regional levels presented ...
Breaking Medicine Technology: